以文本方式查看主题 - 肿瘤咨询在线论坛 (http://www.chinaonco.net/dvbbs/index.asp) -- 『 肿瘤专业 』 (http://www.chinaonco.net/dvbbs/list.asp?boardid=11) ---- 2001年度医学研究领域的热门文章统计 (http://www.chinaonco.net/dvbbs/dispbbs.asp?boardid=11&id=475) |
-- 作者:康华 -- 发布时间:2002-8-22 7:34:31 -- 2001年度医学研究领域的热门文章统计 2001年度医学研究领域的热门文章统计
1、C.Bombardier,et al.,"Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis,"New Engl.J.Med.,New Engl.J.Med.,343(21):1520-8,23 November 2000.[14 institutions worldwide] *375PR Citations This Period (NovDec 01) 50 Rank Last Period (SepOct 01) 2 2、F.E.Silverstein,et al.,"Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis.The CLASS study: a randomized controlled trial,"JAMA-J.Amer.Med.Assn.,284(10): 1247-55,13 September 2000.[12 U.S.institutions] *350WL Citations This Period (Nov-Dec 01) 49 Rank Last Period (Sep-Oct 01) 5 3、S.Yusuf,et al.,"Effects of angiotensin-converting enzyme inhibitor,ramipril,on cardiovascular events in high-risk patients,"New Eng.J.Med.,342(3):145-53,20 January 2000. [Hamilton Gen.Hosp.,Ont.,Canada] *275ZT Citations This Period (Nov-Dec 01) 37 Rank Last Period (Sep-Oct 01) 1 4、P.M.Ridker,et al.,"C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women,"New Engl.J.Med.,342(12):836-43,23 March 2000.[Brigham & Womens Hosp.,Boston,MA;Harvard U.Sch.Med., Boston;Childrens Hosp.,Boston] *296FU Citations This Period (Nov-Dec 01) 32 Rank Last Period (Sep-Oct 01) 3 5、G.R.Bernard,et al.,"Efficacy and safety of recombinant human activated protein C for severe sepsis,"New Engl.J. Med.,344(10):699-709,8 March 2001.[9 institutions worldwide] *408AX Citations This Period (Nov-Dec 01) 30 Rank Last Period (Sep-Oct 01) 8 6、B.J.Druker,et al.,"Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia,"New Engl.J.Med.,344(14):5 April 2001.[Oregon Hlth.Sci.U.,Portland;U.Texas,M.D.Anderson Canc.Ctr.,Houston; Nova Pharmaceut.Corp.,E.Hanover,NJ;U.Calif.,Los Angeles] *417XH Citations This Period (Nov-Dec 01) 29 Rank Last Period (Sep-Oct 01) 7、A.Kugler,et al.,"Regression of human metastatic renal cell carcinoma after vaccination with tumor cell-dendritic cell hybrids,"Nature Medicine,6(3):332-6,March 2000.[U.Gottingen, Germany;U.Tubingen,Germany;Humboldt U.,Berlin,Germany]*288TL Citations This Period (Nov-Dec 01) 31 Rank Last Period (Sep-Oct 01) 5 8、B.J.Druker,et al.,"Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome,"New Engl.J.Med.,344(14):1038-42,5 April 2001.[Oregon Hlth.Sci.U.,Portland;Univ.Calif.,Los Angeles;U.Texas,M.D.Anderson Canc.Ctr.,Houston;Nova Pharmaceut. Corp.,E.Hanover,NJ] *417XH Citations This Period (Nov-Dec 01) 28 Rank Last Period (Sep-Oct 01) 9、A.M.J.Shapiro,et al.,"Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen,"New Engl.J. Med.,343(4):230-8,27 July 2000.[U.Alberta,Edmonton,Canada] 337QC Citations This Period (Nov-Dec 01) 25 Rank Last Period (Sep-Oct 01) 6 10、G.G.Schwartz,et al.,"Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes.The MIRACL study:a randomized controlledtrial,"JAMA-J.Amer.Med. Assn.,285(13):1711-8,4 April 2001.[13 institutions worldwide] *415FR Citations This Period (Nov-Dec 01) 24 Rank Last Period (Sep-Oct 01) SOURCE: ISIs Hot Papers Database
|